Trial Outcomes & Findings for Exploratory Subjective Sleep Study of a Prototype Nasal Dilator (NCT NCT01122849)
NCT ID: NCT01122849
Last Updated: 2018-04-09
Results Overview
The PIRS questionnaire had 3 sections (Section A \[Q1 to Q12\], Section B \[Q13 to 16\] and Section C \[Q17 to Q20\]). The following questions were asked from Section A : 1. One or more awakenings after getting to sleep and 3 Sleep that does not fully refresh you, and Section C: 17 Your sleep quality compared to most people and 18 Your satisfaction with your sleep. Section A question were scored as follows: 0= Not at all bothered, 1= slightly bothered, 2=moderately bothered, and 3= severely bothered. Section B, Q13 and 14 were scored as follows 0= Less than ½ hour, 1= between ½ to 1 hour, 2= between 1 to 3 hours and 3=more than 3 hours or I didn't sleep; Q15 and 16 were scored as 0=more than 7 hours, 1= between 4 to 7 hours, 2= between 2 to 4 hours, and 3=Less than 2 hours or I didn't sleep. Section C questions were scored as follows: 0=Excellent, 1=Good, 2=Fair, and 3=Poor. Lower PIRS score shows better sleep quality.
COMPLETED
PHASE2
61 participants
At Baseline and Day 7
2018-04-09
Participant Flow
Participants were recruited at two centers in USA.
A total of 97 participants were screened for this study, out of which 61 participants were randomized to the study and 36 participants did not meet study criteria.
Participant milestones
| Measure |
Marketed Nasal Strip
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Overall Study
STARTED
|
20
|
21
|
20
|
|
Overall Study
COMPLETED
|
20
|
21
|
20
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Exploratory Subjective Sleep Study of a Prototype Nasal Dilator
Baseline characteristics by cohort
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=21 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=20 Participants
Participants applied the Prototype nasal dilator strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Total
n=61 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Customized
Years
|
46.1 Years
STANDARD_DEVIATION 10.17 • n=99 Participants
|
44.5 Years
STANDARD_DEVIATION 9.59 • n=107 Participants
|
42.5 Years
STANDARD_DEVIATION 13.97 • n=206 Participants
|
44.4 Years
STANDARD_DEVIATION 11.29 • n=7 Participants
|
|
Sex: Female, Male
Female
|
18 Participants
n=99 Participants
|
17 Participants
n=107 Participants
|
15 Participants
n=206 Participants
|
50 Participants
n=7 Participants
|
|
Sex: Female, Male
Male
|
2 Participants
n=99 Participants
|
4 Participants
n=107 Participants
|
5 Participants
n=206 Participants
|
11 Participants
n=7 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
0 Participants
n=7 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
0 Participants
n=7 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
0 Participants
n=7 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
0 Participants
n=7 Participants
|
|
Race (NIH/OMB)
White
|
20 Participants
n=99 Participants
|
21 Participants
n=107 Participants
|
20 Participants
n=206 Participants
|
61 Participants
n=7 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
0 Participants
n=7 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
0 Participants
n=7 Participants
|
PRIMARY outcome
Timeframe: At Baseline and Day 7Population: Analysis for this outcome was performed on intent-to-treat (ITT) population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
The PIRS questionnaire had 3 sections (Section A \[Q1 to Q12\], Section B \[Q13 to 16\] and Section C \[Q17 to Q20\]). The following questions were asked from Section A : 1. One or more awakenings after getting to sleep and 3 Sleep that does not fully refresh you, and Section C: 17 Your sleep quality compared to most people and 18 Your satisfaction with your sleep. Section A question were scored as follows: 0= Not at all bothered, 1= slightly bothered, 2=moderately bothered, and 3= severely bothered. Section B, Q13 and 14 were scored as follows 0= Less than ½ hour, 1= between ½ to 1 hour, 2= between 1 to 3 hours and 3=more than 3 hours or I didn't sleep; Q15 and 16 were scored as 0=more than 7 hours, 1= between 4 to 7 hours, 2= between 2 to 4 hours, and 3=Less than 2 hours or I didn't sleep. Section C questions were scored as follows: 0=Excellent, 1=Good, 2=Fair, and 3=Poor. Lower PIRS score shows better sleep quality.
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 7
Q1
|
-0.911 Score on a scale
Interval -1.21 to -0.61
|
-0.694 Score on a scale
Interval -0.99 to -0.4
|
-1.032 Score on a scale
Interval -1.34 to -0.72
|
|
Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 7
Q3
|
-1.004 Score on a scale
Interval -1.37 to -0.63
|
-0.708 Score on a scale
Interval -1.07 to -0.34
|
-0.947 Score on a scale
Interval -1.33 to -0.56
|
|
Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 7
Q17
|
-0.721 Score on a scale
Interval -1.01 to -0.43
|
-0.349 Score on a scale
Interval -0.63 to -0.07
|
-0.539 Score on a scale
Interval -0.84 to -0.24
|
|
Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 7
Q18
|
-0.643 Score on a scale
Interval -0.91 to -0.38
|
-0.234 Score on a scale
Interval -0.5 to 0.03
|
-0.697 Score on a scale
Interval -0.98 to -0.42
|
PRIMARY outcome
Timeframe: At Baseline and Day 14Population: Analysis for this outcome was performed on intent-to-treat (ITT) population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
Participant were asked questions related to their sleep using PIRS questionnaire. The PIRS questionnaire had 3 sections. Section A (Q1 to Q12), Section B (Q13 to Q16) and Section C (Q17 to Q20). Section A question were scored as follows: 0= Not at all bothered, 1= slightly bothered, 2=moderately bothered, and 3= severely bothered. Section B questions 13 and 14 were scored as follows 0= Less than ½ hour, 1= between ½ to 1 hour, 2= between 1 to 3 hours and 3=more than 3 hours or I didn't sleep; Questions 15 and 16 were scored as 0=more than 7 hours, 1= between 4 to 7 hours, 2= between 2 to 4 hours, and 3=Less than 2 hours or I didn't sleep. Section C questions were scored as follows: 0=Excellent, 1=Good, 2=Fair, and 3=Poor. Lower PIRS score shows better sleep quality.
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 14
Q18 (Your satisfaction with your sleep)
|
-0.873 Score on a scale
Interval -1.18 to -0.57
|
-0.464 Score on a scale
Interval -0.76 to -0.16
|
-0.951 Score on a scale
Interval -1.27 to -0.63
|
|
Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 14
Q1 (One or more awakenings after getting to sleep)
|
-1.047 Score on a scale
Interval -1.36 to -0.74
|
-0.844 Score on a scale
Interval -1.14 to -0.54
|
-1.157 Score on a scale
Interval -1.48 to -0.84
|
|
Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 14
Q3 (Sleep that does not fully refresh you)
|
-1.306 Score on a scale
Interval -1.69 to -0.92
|
-0.917 Score on a scale
Interval -1.3 to -0.54
|
-1.104 Score on a scale
Interval -1.5 to -0.7
|
|
Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 14
Q17 (Your sleep quality compared to most people)
|
-0.714 Score on a scale
Interval -1.04 to -0.39
|
-0.359 Score on a scale
Interval -0.68 to -0.04
|
-0.837 Score on a scale
Interval -1.17 to -0.5
|
PRIMARY outcome
Timeframe: At Baseline and Day 7Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
Participants scored all the domains of NRQLQ using same 7 points scale where 0=Not troubled and 6=extremely troubled. Sleep problems (difficulty getting sleep, unable to get a good night sleep or wake up during the night, restless \[tossing and turning\] and having to get up because stuffy nose or to blow nose using the score, scores range: Min-Max \[0-24\]), Sleep time problems (Nasal congestion or stuffy nose, sinus pressure or pain, runny nose, post-nasal drip \[drainage down back of nose/throat\], and headache, scores range: 0-30); Symptoms on waking in the morning (Feel tired and unrefreshed, nasal congestion or stuffy nose, congestion in sinuses, takes time to clear nighttime drainage after waking up, scores range:0-24); practical problems (have to avoid symptom triggers (such as dust, cigarette smoke, strong smells and perfumes, need to rub nose or eyes, and have to take medication, scores range: 0-18). Lower scores indicate improvement in the rhinitis symptoms.
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Change From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7
Sleep Problems
|
-7.398 Score on a Scale
Interval -9.44 to -5.36
|
-4.194 Score on a Scale
Interval -6.18 to -2.21
|
-6.563 Score on a Scale
Interval -8.71 to -4.42
|
|
Change From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7
Sleep time Problems
|
-7.494 Score on a Scale
Interval -9.99 to -5.0
|
-5.638 Score on a Scale
Interval -8.09 to -3.19
|
-8.212 Score on a Scale
Interval -10.81 to -5.61
|
|
Change From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7
Symptoms on walking in the morning
|
-7.196 Score on a Scale
Interval -9.28 to -5.11
|
-4.074 Score on a Scale
Interval -6.13 to -2.02
|
-7.905 Score on a Scale
Interval -10.09 to -5.72
|
|
Change From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7
Practical Problems
|
-2.774 Score on a Scale
Interval -4.02 to -1.52
|
-2.277 Score on a Scale
Interval -3.51 to -1.04
|
-3.079 Score on a Scale
Interval -4.38 to -1.78
|
PRIMARY outcome
Timeframe: At Baseline and Day 14Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
Participants scored all the domains of NRQLQ using same 7 points scale where 0=Not troubled and 6=extremely troubled. Sleep problems (difficulty getting sleep, unable to get a good night sleep or wake up during the night, restless \[tossing and turning\] and having to get up because stuffy nose or to blow nose using the score, scores range: Min-Max \[0-24\]), Sleep time problems (Nasal congestion or stuffy nose, sinus pressure or pain, runny nose, post-nasal drip \[drainage down back of nose/throat\], and headache, scores range: 0-30); Symptoms on waking in the morning (Feel tired and unrefreshed, nasal congestion or stuffy nose, congestion in sinuses, takes time to clear nighttime drainage after waking up, scores range:0-24); practical problems (have to avoid symptom triggers such as dust, cigarette smoke, strong smells and perfumes, need to rub nose or eyes, and have to take medication, scores range: 0-18). Lower scores indicate improvement in the rhinitis symptoms.
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Change From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 14
Sleep Problems
|
-7.624 Score on a scale
Interval -9.68 to -5.57
|
-5.738 Score on a scale
Interval -7.74 to -3.74
|
-7.051 Score on a scale
Interval -9.21 to -4.89
|
|
Change From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 14
Sleep Time Problems
|
-8.746 Score on a scale
Interval -11.24 to -6.26
|
-7.051 Score on a scale
Interval -9.49 to -4.61
|
-6.768 Score on a scale
Interval -9.36 to -4.18
|
|
Change From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 14
Symptoms on waking in the morning
|
-7.858 Score on a scale
Interval -9.9 to -5.81
|
-5.318 Score on a scale
Interval -7.33 to -3.3
|
-8.001 Score on a scale
Interval -10.14 to -5.86
|
|
Change From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 14
Practical Problems
|
-3.591 Score on a scale
Interval -4.74 to -2.44
|
-3.208 Score on a scale
Interval -4.34 to -2.07
|
-3.054 Score on a scale
Interval -4.25 to -1.86
|
PRIMARY outcome
Timeframe: At Baseline and Day 7Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
Participants answered following questions of CQ7 questionnaire: Q1 -How often did you have nasal stuffiness, blockage, or congestion?, Q2- How often did you have sinus pressure or pain in your face?, Q3-How often did you have to breathe through your mouth because you could not breathe through your nose?, Q4-How often did you have difficulty completely clearing your nose even after repeated blowing?, Q5-How often did any of these symptoms affect your ability to work, learn in school, or do the things you need to do?, Q6-How often did you awaken in the morning with nasal stuffiness, blockage, or congestion?, Q7-How often was your sleep affected by your nasal stuffiness, blockage, or congestion?. Their responses were scored using a 5 point scale where 0=none of the time; 1=a little of the time, 2=some of the time, 3=most of the time, 4=all of the time. Lower CQ7 scores reflect better nasal patency.
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Change From Baseline in Mean Sum of 7 Questions of Congestion Quantifier 7 Questionnaire (CQ7) at Day 7
|
-6.845 Score on a scale
Interval -9.28 to -4.41
|
-5.137 Score on a scale
Interval -7.53 to -2.74
|
-8.184 Score on a scale
Interval -10.75 to -5.62
|
PRIMARY outcome
Timeframe: At Baseline and Day 14Participants answered following questions of CQ7 questionnaire: Q1 -How often did you have nasal stuffiness, blockage, or congestion?, Q2- How often did you have sinus pressure or pain in your face?, Q3-How often did you have to breathe through your mouth because you could not breathe through your nose?, Q4-How often did you have difficulty completely clearing your nose even after repeated blowing?, Q5-How often did any of these symptoms affect your ability to work, learn in school, or do the things you need to do?, Q6-How often did you awaken in the morning with nasal stuffiness, blockage, or congestion?, Q7-How often was your sleep affected by your nasal stuffiness, blockage, or congestion?. Their responses were scored using a 5 point scale where 0=none of the time; 1=a little of the time, 2=some of the time, 3=most of the time, 4=all of the time. Lowe CQ7 scores reflect better nasal patency.
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Change From Baseline in Mean Sum of 7 Questions of Congestion Quantifier 7 Questionnaire (CQ7) at Day 14
|
-8.035 Score on a Scale
Interval -10.34 to -5.73
|
-5.102 Score on a Scale
Interval -7.37 to -2.83
|
-6.917 Score on a Scale
Interval -9.35 to -4.49
|
PRIMARY outcome
Timeframe: Day 7Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
Participants were asked how easy it was to breathe through their nose before and after strip application at bedtime. The participants scored their responses on 100 point VAS scale where 0 = extremely difficult to breathe and 100 = extremely easy to breathe. These responses were recorded daily.
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=19 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime on Day 7
Before strip application
|
32.10 Score on scale
Standard Deviation 22.386
|
36.37 Score on scale
Standard Deviation 21.945
|
40.53 Score on scale
Standard Deviation 18.234
|
|
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime on Day 7
After strip application
|
58.95 Score on scale
Standard Deviation 28.543
|
47.42 Score on scale
Standard Deviation 26.742
|
61.11 Score on scale
Standard Deviation 21.787
|
|
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime on Day 7
Change from Baseline
|
23.25 Score on scale
Standard Deviation 72.4
|
8.75 Score on scale
Standard Deviation 24.0
|
18.89 Score on scale
Standard Deviation 46.6
|
PRIMARY outcome
Timeframe: Day 14Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
Participants were asked how easy it was to breathe through their nose before and after strip application at bedtime. The participants scored their responses on 100 point VAS scale where 0 = extremely difficult to breathe and 100 = extremely easy to breathe. These responses were recorded daily.
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime on Day 14
Before strip application
|
39.90 Score on a scale
Standard Deviation 24.070
|
43.21 Score on a scale
Standard Deviation 24.001
|
45.89 Score on a scale
Standard Deviation 22.292
|
|
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime on Day 14
After strip application
|
68.70 Score on a scale
Standard Deviation 26.636
|
51.05 Score on a scale
Standard Deviation 25.387
|
67.56 Score on a scale
Standard Deviation 23.605
|
PRIMARY outcome
Timeframe: Day 7Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
Participants were asked how easy it was to breathe through their nose before and after strip removal in morning. The participants scored their responses on 100 point VAS scale where 0 = extremely difficult to breathe and 100 = extremely easy to breathe. These responses were recorded daily.
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Removal in Morning on Day 7
Before strip removal
|
60.15 Score on a Scale
Standard Deviation 25.522
|
46.95 Score on a Scale
Standard Deviation 25.888
|
62.63 Score on a Scale
Standard Deviation 19.774
|
|
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Removal in Morning on Day 7
After strip removal
|
43.10 Score on a Scale
Standard Deviation 21.711
|
44.74 Score on a Scale
Standard Deviation 25.236
|
60.00 Score on a Scale
Standard Deviation 21.654
|
PRIMARY outcome
Timeframe: Day 14Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
Participants were asked how easy it was to breathe through their nose before and after strip removal in morning. The participants scored their responses on 100 point VAS scale where 0=extremely difficult to breathe and 100=extremely easy
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Removal in Morning on Day 14.
Before Strip Removal
|
67.80 Score on a scale
Standard Deviation 24.816
|
48.95 Score on a scale
Standard Deviation 26.511
|
70.61 Score on a scale
Standard Deviation 22.078
|
|
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Removal in Morning on Day 14.
After Strip Removal
|
51.35 Score on a scale
Standard Deviation 25.203
|
45.26 Score on a scale
Standard Deviation 25.473
|
61.11 Score on a scale
Standard Deviation 21.978
|
PRIMARY outcome
Timeframe: Day 7Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
Questions regarding nasal strips were asked to participants and scores were noted on daily basis. Participants were asked how stuffed their nose felt before and after strip application (Q2) and how breathing felt after strip was applied (Q4) at bedtime. For Q2 the participants scored their responses on a scale of 0 to 3 where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, 3=severe symptoms. For Q4, participants scored their responses on a scale of -5 to 5 where -5=much worse, 0=same, and 5=much better (Q4 was asked after strip application only therefore no data for before application is available for Q4.)
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Mean Score in Response to Daily Diary Questions (Q2 and Q4) at Bedtime on Day 7
Before strip application (Q2)
|
1.75 Score on a Scale
Standard Deviation 0.550
|
1.70 Score on a Scale
Standard Deviation 0.733
|
1.63 Score on a Scale
Standard Deviation 0.597
|
|
Mean Score in Response to Daily Diary Questions (Q2 and Q4) at Bedtime on Day 7
After strip application (Q2)
|
1.00 Score on a Scale
Standard Deviation 0.795
|
1.55 Score on a Scale
Standard Deviation 0.887
|
1.16 Score on a Scale
Standard Deviation 0.688
|
|
Mean Score in Response to Daily Diary Questions (Q2 and Q4) at Bedtime on Day 7
After strip application (Q4)
|
2.80 Score on a Scale
Standard Deviation 1.399
|
1.20 Score on a Scale
Standard Deviation 1.473
|
1.79 Score on a Scale
Standard Deviation 1.475
|
PRIMARY outcome
Timeframe: Day 14Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
Questions regarding nasal strips were asked to participants and scores were noted on daily basis. Participants were asked how stuffed their nose felt before and after strip application (Q2) and how breathing felt after strip was applied (Q4) at bedtime. For Q2, the participants scored their responses on a scale of 0 to 3 where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, 3=severe symptoms. For Q4, participants scored their responses on a scale of -5 to 5 where -5=much worse, 0=same, and 5=much better (Q4 was asked after strip application only therefore no data for before application is available for question 4.)
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Mean Score in Response to Daily Diary Questions (Q2 and Q4) at Bedtime on Day 14
Before strip application (Q2)
|
1.40 Score on a scale
Standard Deviation 0.598
|
1.58 Score on a scale
Standard Deviation 0.607
|
1.61 Score on a scale
Standard Deviation 0.698
|
|
Mean Score in Response to Daily Diary Questions (Q2 and Q4) at Bedtime on Day 14
After strip application (Q2)
|
0.85 Score on a scale
Standard Deviation 0.875
|
1.35 Score on a scale
Standard Deviation 0.786
|
1.06 Score on a scale
Standard Deviation 0.873
|
|
Mean Score in Response to Daily Diary Questions (Q2 and Q4) at Bedtime on Day 14
After strip application (Q4)
|
2.70 Score on a scale
Standard Deviation 1.658
|
0.89 Score on a scale
Standard Deviation 1.410
|
2.00 Score on a scale
Standard Deviation 1.715
|
PRIMARY outcome
Timeframe: Day 7Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
Questions regarding nasal strips were asked to participants and scores were noted on daily basis. Participants were asked how stuffed their nose felt before and after strip removal (Q2) and how breathing felt after strip was removed (Q4) in morning. For Q2 the participants scored their responses on a scale of 0 to 3 where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, 3=severe symptoms. For Q4, participants scored their responses on a scale of -5 to 5 where -5=much worse, 0=same, and 5=much better. (Q4 was asked after strip removal only therefore no data for before removal is available for question 4.)
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Mean Score in Response to Daily Diary Questions (Q2 and Q4) in Morning on Day 7
Before strip removal (Q2)
|
1.00 Score on a scale
Standard Deviation 0.649
|
1.60 Score on a scale
Standard Deviation 0.995
|
1.00 Score on a scale
Standard Deviation 0.745
|
|
Mean Score in Response to Daily Diary Questions (Q2 and Q4) in Morning on Day 7
After strip removal (Q2)
|
1.35 Score on a scale
Standard Deviation 0.671
|
1.75 Score on a scale
Standard Deviation 0.967
|
1.11 Score on a scale
Standard Deviation 0.809
|
|
Mean Score in Response to Daily Diary Questions (Q2 and Q4) in Morning on Day 7
After strip removal (Q4)
|
-0.20 Score on a scale
Standard Deviation 2.118
|
0.60 Score on a scale
Standard Deviation 1.759
|
1.16 Score on a scale
Standard Deviation 2.007
|
PRIMARY outcome
Timeframe: Day 14Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
Questions regarding nasal strips were asked to participants and scores were noted on daily basis. Participants were asked how stuffed their nose felt before and after strip removal (Q2) and how breathing felt after strip was removed (Q4) in morning. For Q2 the participants scored their responses on a scale of 0 to 3 where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, 3=severe symptoms. For Q4, participants scored their responses on a scale of -5 to 5 where -5=much worse, 0=same, and 5=much better (Q4 was asked after strip removal only therefore no data for before removal is available for question 4.)
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Mean Score in Response to Daily Diary Questions (Q2 and Q4) in Morning on Day 14
Before strip removal (Q2)
|
0.95 Score ona scale
Standard Deviation 0.826
|
1.40 Score ona scale
Standard Deviation 0.940
|
0.89 Score ona scale
Standard Deviation 0.832
|
|
Mean Score in Response to Daily Diary Questions (Q2 and Q4) in Morning on Day 14
After strip removal (Q2)
|
1.30 Score ona scale
Standard Deviation 0.657
|
1.45 Score ona scale
Standard Deviation 0.887
|
1.17 Score ona scale
Standard Deviation 0.707
|
|
Mean Score in Response to Daily Diary Questions (Q2 and Q4) in Morning on Day 14
After strip removal (Q4)
|
-0.45 Score ona scale
Standard Deviation 2.282
|
0.60 Score ona scale
Standard Deviation 1.536
|
0.94 Score ona scale
Standard Deviation 2.261
|
SECONDARY outcome
Timeframe: At Day 7 and Day 14The following questions were asked from Section A (Q1 to Q12; 2 Not getting enough sleep, 4 Poor alertness during the daytime, 5 Difficulty keeping your thoughts focused, 6 Others noticing you appeared tired or fatigued, 7 too many difficulties to overcome, 8 Bad moods because you had poor sleep, 9 Lack of energy because of poor sleep, 10 Poor sleep that interferes with your relationships, 11 Being unable to sleep, 12 Being able to do only enough to get by, Section B (Q13 to Q16; 13 From the time you tried to go to sleep, How long did it take to fall asleep on most nights, 14 If you woke during the night, how long did it take to fall back to sleep on most nights,15 Not counting times when you were awake in bed, how many hours of actual sleep did you get during the worst night, 16 On how many days did you have trouble coping because of poor sleep and Section C (Q17 to Q20;, 19 The regularity of your sleep, 20 The soundness of your sleep)
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Summary for Other Questions of PIRS Questionnaire
Q2 (Day 7)
|
1.20 Score on a Scale
Standard Deviation 0.894
|
1.40 Score on a Scale
Standard Deviation 0.883
|
1.37 Score on a Scale
Standard Deviation 0.831
|
|
Summary for Other Questions of PIRS Questionnaire
Q2 (Day 14)
|
0.90 Score on a Scale
Standard Deviation 0.788
|
1.20 Score on a Scale
Standard Deviation 0.834
|
0.95 Score on a Scale
Standard Deviation 0.705
|
|
Summary for Other Questions of PIRS Questionnaire
Q4 (Day7)
|
0.75 Score on a Scale
Standard Deviation 0.786
|
1.05 Score on a Scale
Standard Deviation 0.945
|
0.84 Score on a Scale
Standard Deviation 0.834
|
|
Summary for Other Questions of PIRS Questionnaire
Q4 (Day 14)
|
0.65 Score on a Scale
Standard Deviation 0.745
|
0.90 Score on a Scale
Standard Deviation 0.788
|
0.63 Score on a Scale
Standard Deviation 0.684
|
|
Summary for Other Questions of PIRS Questionnaire
Q5 (Day 7)
|
0.65 Score on a Scale
Standard Deviation 0.671
|
0.85 Score on a Scale
Standard Deviation 0.813
|
0.63 Score on a Scale
Standard Deviation 0.684
|
|
Summary for Other Questions of PIRS Questionnaire
Q5 (Day 14)
|
0.55 Score on a Scale
Standard Deviation 0.605
|
0.65 Score on a Scale
Standard Deviation 0.813
|
0.63 Score on a Scale
Standard Deviation 0.597
|
|
Summary for Other Questions of PIRS Questionnaire
Q6 (Day 7)
|
0.50 Score on a Scale
Standard Deviation 0.827
|
0.70 Score on a Scale
Standard Deviation 0.923
|
0.68 Score on a Scale
Standard Deviation 0.820
|
|
Summary for Other Questions of PIRS Questionnaire
Q6 (Day 14)
|
0.50 Score on a Scale
Standard Deviation 0.761
|
0.60 Score on a Scale
Standard Deviation 0.754
|
0.58 Score on a Scale
Standard Deviation 0.692
|
|
Summary for Other Questions of PIRS Questionnaire
Q7 (Day 7)
|
0.45 Score on a Scale
Standard Deviation 0.686
|
0.60 Score on a Scale
Standard Deviation 0.883
|
0.37 Score on a Scale
Standard Deviation 0.597
|
|
Summary for Other Questions of PIRS Questionnaire
Q7 (Day 14)
|
0.45 Score on a Scale
Standard Deviation 0.826
|
0.40 Score on a Scale
Standard Deviation 0.681
|
0.32 Score on a Scale
Standard Deviation 0.478
|
|
Summary for Other Questions of PIRS Questionnaire
Q8 (Day 7)
|
0.65 Score on a Scale
Standard Deviation 0.813
|
0.80 Score on a Scale
Standard Deviation 0.894
|
0.63 Score on a Scale
Standard Deviation 0.684
|
|
Summary for Other Questions of PIRS Questionnaire
Q8 (Day 14)
|
0.65 Score on a Scale
Standard Deviation 0.745
|
0.55 Score on a Scale
Standard Deviation 0.686
|
0.37 Score on a Scale
Standard Deviation 0.597
|
|
Summary for Other Questions of PIRS Questionnaire
Q9 (Day 7)
|
0.95 Score on a Scale
Standard Deviation 0.826
|
1.40 Score on a Scale
Standard Deviation 0.995
|
0.89 Score on a Scale
Standard Deviation 0.658
|
|
Summary for Other Questions of PIRS Questionnaire
Q9 (Day 14)
|
0.80 Score on a Scale
Standard Deviation 0.834
|
0.85 Score on a Scale
Standard Deviation 0.813
|
0.68 Score on a Scale
Standard Deviation 0.749
|
|
Summary for Other Questions of PIRS Questionnaire
Q10 (Day 7)
|
0.60 Score on a Scale
Standard Deviation 0.883
|
0.60 Score on a Scale
Standard Deviation 0.940
|
0.37 Score on a Scale
Standard Deviation 0.597
|
|
Summary for Other Questions of PIRS Questionnaire
Q10 (Day 14)
|
0.40 Score on a Scale
Standard Deviation 0.754
|
0.55 Score on a Scale
Standard Deviation 0.887
|
0.37 Score on a Scale
Standard Deviation 0.597
|
|
Summary for Other Questions of PIRS Questionnaire
Q11 (Day 7)
|
0.70 Score on a Scale
Standard Deviation 0.801
|
1.30 Score on a Scale
Standard Deviation 0.979
|
1.00 Score on a Scale
Standard Deviation 0.745
|
|
Summary for Other Questions of PIRS Questionnaire
Q11 (Day 14)
|
0.70 Score on a Scale
Standard Deviation 0.865
|
1.05 Score on a Scale
Standard Deviation 0.887
|
0.68 Score on a Scale
Standard Deviation 0.749
|
|
Summary for Other Questions of PIRS Questionnaire
Q12 (Day 7)
|
0.40 Score on a Scale
Standard Deviation 0.754
|
0.70 Score on a Scale
Standard Deviation 0.733
|
0.63 Score on a Scale
Standard Deviation 0.761
|
|
Summary for Other Questions of PIRS Questionnaire
Q12 (Day 14)
|
0.30 Score on a Scale
Standard Deviation 0.733
|
0.60 Score on a Scale
Standard Deviation 0.821
|
0.32 Score on a Scale
Standard Deviation 0.582
|
|
Summary for Other Questions of PIRS Questionnaire
Q13 (Day 7)
|
0.45 Score on a Scale
Standard Deviation 0.605
|
0.70 Score on a Scale
Standard Deviation 0.733
|
0.74 Score on a Scale
Standard Deviation 0.733
|
|
Summary for Other Questions of PIRS Questionnaire
Q13 (Day 14)
|
0.55 Score on a Scale
Standard Deviation 0.605
|
0.60 Score on a Scale
Standard Deviation 0.754
|
0.63 Score on a Scale
Standard Deviation 0.761
|
|
Summary for Other Questions of PIRS Questionnaire
Q14 (Day 7)
|
0.35 Score on a Scale
Standard Deviation 0.489
|
0.65 Score on a Scale
Standard Deviation 0.745
|
0.53 Score on a Scale
Standard Deviation 0.697
|
|
Summary for Other Questions of PIRS Questionnaire
Q14 (Day 14)
|
0.45 Score on a Scale
Standard Deviation 0.605
|
0.55 Score on a Scale
Standard Deviation 0.605
|
0.53 Score on a Scale
Standard Deviation 0.612
|
|
Summary for Other Questions of PIRS Questionnaire
Q15 (Day 7)
|
1.00 Score on a Scale
Standard Deviation 0.324
|
1.20 Score on a Scale
Standard Deviation 0.616
|
1.32 Score on a Scale
Standard Deviation 0.582
|
|
Summary for Other Questions of PIRS Questionnaire
Q15 (Day 14)
|
1.05 Score on a Scale
Standard Deviation 0.394
|
1.05 Score on a Scale
Standard Deviation 0.510
|
1.05 Score on a Scale
Standard Deviation 0.621
|
|
Summary for Other Questions of PIRS Questionnaire
Q16 (Day 7)
|
0.40 Score on a Scale
Standard Deviation 0.754
|
0.74 Score on a Scale
Standard Deviation 0.933
|
0.47 Score on a Scale
Standard Deviation 0.697
|
|
Summary for Other Questions of PIRS Questionnaire
Q16 (Day 14)
|
0.25 Score on a Scale
Standard Deviation 0.716
|
0.50 Score on a Scale
Standard Deviation 0.688
|
0.32 Score on a Scale
Standard Deviation 0.582
|
|
Summary for Other Questions of PIRS Questionnaire
Q 19 (Day 7)
|
1.40 Score on a Scale
Standard Deviation 0.754
|
2.00 Score on a Scale
Standard Deviation 0.795
|
1.68 Score on a Scale
Standard Deviation 0.671
|
|
Summary for Other Questions of PIRS Questionnaire
Q19 (Day 14)
|
1.35 Score on a Scale
Standard Deviation 0.587
|
1.70 Score on a Scale
Standard Deviation 0.865
|
1.26 Score on a Scale
Standard Deviation 0.733
|
|
Summary for Other Questions of PIRS Questionnaire
Q20 (Day 7)
|
1.30 Score on a Scale
Standard Deviation 0.923
|
1.85 Score on a Scale
Standard Deviation 0.933
|
1.63 Score on a Scale
Standard Deviation 0.684
|
|
Summary for Other Questions of PIRS Questionnaire
Q20 (Day 14)
|
1.40 Score on a Scale
Standard Deviation 0.821
|
1.75 Score on a Scale
Standard Deviation 0.967
|
1.21 Score on a Scale
Standard Deviation 0.713
|
SECONDARY outcome
Timeframe: At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment
Participants were asked how easy it was to breathe through their nose before and after strip application at bedtime. The participants scored their responses on VAS scale where 0 = extremely difficult to breathe and 100 = extremely easy to breathe. These responses were recorded daily.
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 3)
|
58.90 Score on a scale
Standard Deviation 26.638
|
48.53 Score on a scale
Standard Deviation 20.665
|
61.42 Score on a scale
Standard Deviation 24.739
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 1)
|
27.85 Score on a scale
Standard Deviation 20.582
|
34.58 Score on a scale
Standard Deviation 15.798
|
34.00 Score on a scale
Standard Deviation 14.821
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 1)
|
61.55 Score on a scale
Standard Deviation 26.716
|
43.11 Score on a scale
Standard Deviation 24.071
|
55.00 Score on a scale
Standard Deviation 24.866
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 2)
|
28.2 Score on a scale
Standard Deviation 20.18
|
37.2 Score on a scale
Standard Deviation 23.18
|
42.7 Score on a scale
Standard Deviation 19.26
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 2)
|
60.1 Score on a scale
Standard Deviation 26.16
|
45.2 Score on a scale
Standard Deviation 25.04
|
60.7 Score on a scale
Standard Deviation 22.36
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 3)
|
29.35 Score on a scale
Standard Deviation 20.296
|
37.95 Score on a scale
Standard Deviation 19.842
|
45.11 Score on a scale
Standard Deviation 23.870
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 4)
|
32.8 Score on a scale
Standard Deviation 20.87
|
33.3 Score on a scale
Standard Deviation 14.27
|
36.4 Score on a scale
Standard Deviation 19.29
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After Strip application (Day 4)
|
60.8 Score on a scale
Standard Deviation 28.86
|
45.7 Score on a scale
Standard Deviation 17.89
|
60.2 Score on a scale
Standard Deviation 22.14
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 5)
|
33.2 Score on a scale
Standard Deviation 23.45
|
36.9 Score on a scale
Standard Deviation 19.78
|
41.4 Score on a scale
Standard Deviation 21.85
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 5)
|
64.9 Score on a scale
Standard Deviation 28.11
|
47.5 Score on a scale
Standard Deviation 22.51
|
63.8 Score on a scale
Standard Deviation 23.95
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 6)
|
28.6 Score on a scale
Standard Deviation 22.47
|
35.9 Score on a scale
Standard Deviation 20.29
|
44.9 Score on a scale
Standard Deviation 18.55
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 6)
|
60.5 Score on a scale
Standard Deviation 30.06
|
44.8 Score on a scale
Standard Deviation 21.28
|
64.3 Score on a scale
Standard Deviation 20.03
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 8)
|
35.4 Score on a scale
Standard Deviation 22.08
|
38.6 Score on a scale
Standard Deviation 21.38
|
45.5 Score on a scale
Standard Deviation 19.18
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 8)
|
61.2 Score on a scale
Standard Deviation 26.41
|
47.8 Score on a scale
Standard Deviation 25.07
|
65.0 Score on a scale
Standard Deviation 22.96
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 9)
|
32.7 Score on a scale
Standard Deviation 24.11
|
40.0 Score on a scale
Standard Deviation 21.18
|
45.6 Score on a scale
Standard Deviation 19.90
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 9)
|
61.2 Score on a scale
Standard Deviation 27.90
|
48.6 Score on a scale
Standard Deviation 24.45
|
63.4 Score on a scale
Standard Deviation 22.45
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 10)
|
36.9 Score on a scale
Standard Deviation 25.80
|
42.7 Score on a scale
Standard Deviation 27.71
|
40.6 Score on a scale
Standard Deviation 19.74
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 10)
|
68.3 Score on a scale
Standard Deviation 27.76
|
50.2 Score on a scale
Standard Deviation 30.15
|
60.9 Score on a scale
Standard Deviation 24.91
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 11)
|
66.3 Score on a scale
Standard Deviation 26.45
|
49.8 Score on a scale
Standard Deviation 25.18
|
63.2 Score on a scale
Standard Deviation 25.60
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 11)
|
33.6 Score on a scale
Standard Deviation 25.33
|
40.2 Score on a scale
Standard Deviation 22.99
|
42.1 Score on a scale
Standard Deviation 21.52
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 12)
|
32.7 Score on a scale
Standard Deviation 25.79
|
42.5 Score on a scale
Standard Deviation 24.96
|
47.5 Score on a scale
Standard Deviation 21.51
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 12)
|
66.8 Score on a scale
Standard Deviation 27.43
|
52.8 Score on a scale
Standard Deviation 26.46
|
65.7 Score on a scale
Standard Deviation 23.44
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 13)
|
33.9 Score on a scale
Standard Deviation 27.28
|
43.5 Score on a scale
Standard Deviation 23.07
|
48.1 Score on a scale
Standard Deviation 24.12
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 13)
|
66.7 Score on a scale
Standard Deviation 26.62
|
53.1 Score on a scale
Standard Deviation 26.16
|
67.8 Score on a scale
Standard Deviation 24.38
|
SECONDARY outcome
Timeframe: At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
Participants were asked how easy it was to breathe through their nose before and after strip removal in morning. The participants scored their responses on VAS scale where 0 = extremely difficult to breathe and 100 = extremely easy to breathe. These responses were recorded daily.
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 1)
|
54.60 Score on a scale
Standard Deviation 30.407
|
45.11 Score on a scale
Standard Deviation 22.588
|
60.44 Score on a scale
Standard Deviation 20.024
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 1)
|
44.75 Score on a scale
Standard Deviation 21.560
|
41.47 Score on a scale
Standard Deviation 20.018
|
51.44 Score on a scale
Standard Deviation 20.569
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 2)
|
61.0 Score on a scale
Standard Deviation 26.25
|
44.1 Score on a scale
Standard Deviation 22.56
|
60.0 Score on a scale
Standard Deviation 22.85
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 2)
|
46.8 Score on a scale
Standard Deviation 21.80
|
42.1 Score on a scale
Standard Deviation 22.34
|
51.2 Score on a scale
Standard Deviation 21.76
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 3)
|
63.60 Score on a scale
Standard Deviation 27.582
|
48.37 Score on a scale
Standard Deviation 23.864
|
60.21 Score on a scale
Standard Deviation 24.114
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 3)
|
44.90 Score on a scale
Standard Deviation 21.071
|
45.53 Score on a scale
Standard Deviation 23.236
|
56.79 Score on a scale
Standard Deviation 21.578
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 4)
|
64.9 Score on a scale
Standard Deviation 26.35
|
50.0 Score on a scale
Standard Deviation 19.06
|
62.8 Score on a scale
Standard Deviation 21.56
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 4)
|
49.2 Score on a scale
Standard Deviation 23.37
|
45.9 Score on a scale
Standard Deviation 21.27
|
53.6 Score on a scale
Standard Deviation 20.99
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 5)
|
65.0 Score on a scale
Standard Deviation 27.48
|
47.4 Score on a scale
Standard Deviation 21.94
|
64.0 Score on a scale
Standard Deviation 20.90
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 5)
|
49.7 Score on a scale
Standard Deviation 23.50
|
43.4 Score on a scale
Standard Deviation 23.21
|
58.1 Score on a scale
Standard Deviation 19.31
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 6)
|
60.9 Score on a scale
Standard Deviation 27.34
|
46.2 Score on a scale
Standard Deviation 23.94
|
63.1 Score on a scale
Standard Deviation 21.40
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 6)
|
47.0 Score on a scale
Standard Deviation 24.03
|
42.4 Score on a scale
Standard Deviation 23.16
|
58.6 Score on a scale
Standard Deviation 18.40
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 8)
|
64.7 Score on a scale
Standard Deviation 25.34
|
43.6 Score on a scale
Standard Deviation 25.55
|
65.2 Score on a scale
Standard Deviation 20.39
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 8)
|
46.6 Score on a scale
Standard Deviation 25.50
|
40.7 Score on a scale
Standard Deviation 24.07
|
60.4 Score on a scale
Standard Deviation 19.35
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 9)
|
61.1 Score on a scale
Standard Deviation 27.82
|
46.7 Score on a scale
Standard Deviation 24.68
|
65.1 Score on a scale
Standard Deviation 23.06
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 9)
|
49.0 Score on a scale
Standard Deviation 26.34
|
41.7 Score on a scale
Standard Deviation 24.08
|
59.5 Score on a scale
Standard Deviation 20.19
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 10)
|
66.2 Score on a scale
Standard Deviation 25.85
|
45.6 Score on a scale
Standard Deviation 26.88
|
65.4 Score on a scale
Standard Deviation 22.52
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 10)
|
50.6 Score on a scale
Standard Deviation 24.92
|
42.4 Score on a scale
Standard Deviation 26.57
|
57.5 Score on a scale
Standard Deviation 22.10
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 11)
|
62.3 Score on a scale
Standard Deviation 26.37
|
47.3 Score on a scale
Standard Deviation 25.79
|
67.5 Score on a scale
Standard Deviation 20.50
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 11)
|
46.4 Score on a scale
Standard Deviation 23.93
|
42.2 Score on a scale
Standard Deviation 23.98
|
57.0 Score on a scale
Standard Deviation 19.91
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 12)
|
63.8 Score on a scale
Standard Deviation 25.58
|
49.2 Score on a scale
Standard Deviation 24.95
|
67.6 Score on a scale
Standard Deviation 21.03
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 12)
|
48.7 Score on a scale
Standard Deviation 27.39
|
46.3 Score on a scale
Standard Deviation 23.45
|
59.4 Score on a scale
Standard Deviation 21.30
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 13)
|
64.3 Score on a scale
Standard Deviation 25.58
|
46.4 Score on a scale
Standard Deviation 26.18
|
68.4 Score on a scale
Standard Deviation 22.84
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 13)
|
46.6 Score on a scale
Standard Deviation 27.39
|
43.3 Score on a scale
Standard Deviation 26.37
|
60.0 Score on a scale
Standard Deviation 21.02
|
SECONDARY outcome
Timeframe: At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
Participants were asked how open their nose feels before and after strip application at bedtime. The participants scored their responses VAS scale where 0 = nose was extremely blocked and 100 = nose was extremely clear. These responses were recorded daily.
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 1)
|
27.90 Score on a Scale
Standard Deviation 20.463
|
37.74 Score on a Scale
Standard Deviation 17.143
|
35.89 Score on a Scale
Standard Deviation 14.644
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 1)
|
61.45 Score on a Scale
Standard Deviation 25.853
|
45.84 Score on a Scale
Standard Deviation 23.061
|
57.68 Score on a Scale
Standard Deviation 22.583
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 2)
|
27.5 Score on a Scale
Standard Deviation 19.64
|
38.3 Score on a Scale
Standard Deviation 22.17
|
42.2 Score on a Scale
Standard Deviation 19.49
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 2)
|
59.8 Score on a Scale
Standard Deviation 26.90
|
47.0 Score on a Scale
Standard Deviation 24.10
|
63.2 Score on a Scale
Standard Deviation 63.2
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 3)
|
30.05 Score on a Scale
Standard Deviation 20.405
|
38.32 Score on a Scale
Standard Deviation 19.285
|
46.42 Score on a Scale
Standard Deviation 24.132
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 3)
|
59.25 Score on a Scale
Standard Deviation 27.466
|
49.74 Score on a Scale
Standard Deviation 22.098
|
62.16 Score on a Scale
Standard Deviation 24.847
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 4)
|
32.6 Score on a Scale
Standard Deviation 20.51
|
33.6 Score on a Scale
Standard Deviation 14.78
|
36.6 Score on a Scale
Standard Deviation 18.74
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 4)
|
60.5 Score on a Scale
Standard Deviation 28.31
|
46.7 Score on a Scale
Standard Deviation 17.34
|
61.1 Score on a Scale
Standard Deviation 23.41
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 5)
|
33.4 Score on a Scale
Standard Deviation 23.85
|
36.1 Score on a Scale
Standard Deviation 19.57
|
42.1 Score on a Scale
Standard Deviation 21.60
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip appliation (Day 5)
|
65.6 Score on a Scale
Standard Deviation 28.44
|
49.3 Score on a Scale
Standard Deviation 22.62
|
66.7 Score on a Scale
Standard Deviation 23.97
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 6)
|
26.7 Score on a Scale
Standard Deviation 20.58
|
35.3 Score on a Scale
Standard Deviation 18.59
|
44.8 Score on a Scale
Standard Deviation 20.14
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 6)
|
60.5 Score on a Scale
Standard Deviation 28.86
|
43.9 Score on a Scale
Standard Deviation 19.34
|
66.5 Score on a Scale
Standard Deviation 20.92
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 8)
|
33.9 Score on a Scale
Standard Deviation 21.15
|
37.9 Score on a Scale
Standard Deviation 22.54
|
46.9 Score on a Scale
Standard Deviation 20.76
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 8)
|
63.4 Score on a Scale
Standard Deviation 26.94
|
46.5 Score on a Scale
Standard Deviation 24.74
|
67.5 Score on a Scale
Standard Deviation 67.5
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 9)
|
32.7 Score on a Scale
Standard Deviation 24.42
|
37.6 Score on a Scale
Standard Deviation 20.70
|
45.8 Score on a Scale
Standard Deviation 21.77
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 9)
|
65.6 Score on a Scale
Standard Deviation 26.71
|
49.5 Score on a Scale
Standard Deviation 25.34
|
65.5 Score on a Scale
Standard Deviation 23.09
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 10)
|
36.2 Score on a Scale
Standard Deviation 42.1
|
42.1 Score on a Scale
Standard Deviation 26.94
|
41.8 Score on a Scale
Standard Deviation 22.31
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 10)
|
68.7 Score on a Scale
Standard Deviation 26.85
|
52.1 Score on a Scale
Standard Deviation 30.45
|
63.0 Score on a Scale
Standard Deviation 25.34
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 11)
|
35.4 Score on a Scale
Standard Deviation 24.79
|
41.3 Score on a Scale
Standard Deviation 23.74
|
41.3 Score on a Scale
Standard Deviation 22.54
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 11)
|
67.3 Score on a Scale
Standard Deviation 26.69
|
50.5 Score on a Scale
Standard Deviation 27.02
|
64.8 Score on a Scale
Standard Deviation 25.15
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 12)
|
34.7 Score on a Scale
Standard Deviation 26.71
|
44.2 Score on a Scale
Standard Deviation 24.78
|
47.5 Score on a Scale
Standard Deviation 23.30
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 12)
|
68.4 Score on a Scale
Standard Deviation 26.67
|
53.4 Score on a Scale
Standard Deviation 26.40
|
67.5 Score on a Scale
Standard Deviation 23.95
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 13)
|
34.9 Score on a Scale
Standard Deviation 26.36
|
42.7 Score on a Scale
Standard Deviation 23.58
|
50.3 Score on a Scale
Standard Deviation 24.75
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 13)
|
67.1 Score on a Scale
Standard Deviation 25.90
|
53.6 Score on a Scale
Standard Deviation 25.74
|
68.1 Score on a Scale
Standard Deviation 25.28
|
SECONDARY outcome
Timeframe: At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
Participants were asked how open their nose feels before and after strip removal in morning. The participants scored their responses VAS scale where 0 = nose was extremely blocked and 100 = nose was extremely clear. These responses were recorded daily.
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 1)
|
53.95 Score on a Scale
Standard Deviation 29.883
|
45.37 Score on a Scale
Standard Deviation 25.049
|
60.22 Score on a Scale
Standard Deviation 21.198
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 1)
|
44.70 Score on a Scale
Standard Deviation 22.181
|
42.53 Score on a Scale
Standard Deviation 20.291
|
51.56 Score on a Scale
Standard Deviation 22.727
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 2)
|
60.8 Score on a Scale
Standard Deviation 26.46
|
43.7 Score on a Scale
Standard Deviation 20.85
|
60.6 Score on a Scale
Standard Deviation 23.48
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 2)
|
45.7 Score on a Scale
Standard Deviation 23.56
|
43.4 Score on a Scale
Standard Deviation 22.56
|
53.1 Score on a Scale
Standard Deviation 22.81
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 3)
|
61.35 Score on a Scale
Standard Deviation 27.871
|
46.89 Score on a Scale
Standard Deviation 23.812
|
60.53 Score on a Scale
Standard Deviation 24.688
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 3)
|
44.30 Score on a Scale
Standard Deviation 21.440
|
45.47 Score on a Scale
Standard Deviation 22.473
|
58.11 Score on a Scale
Standard Deviation 22.652
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 4)
|
63.7 Score on a Scale
Standard Deviation 25.51
|
48.2 Score on a Scale
Standard Deviation 19.23
|
64.7 Score on a Scale
Standard Deviation 22.55
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 4)
|
48.3 Score on a Scale
Standard Deviation 22.10
|
45.5 Score on a Scale
Standard Deviation 21.18
|
55.1 Score on a Scale
Standard Deviation 21.13
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 5)
|
65.2 Score on a Scale
Standard Deviation 27.66
|
45.2 Score on a Scale
Standard Deviation 23.74
|
64.4 Score on a Scale
Standard Deviation 20.52
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 5)
|
49.3 Score on a Scale
Standard Deviation 25.08
|
43.4 Score on a Scale
Standard Deviation 23.30
|
59.6 Score on a Scale
Standard Deviation 20.14
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 6)
|
60.4 Score on a Scale
Standard Deviation 27.25
|
45.9 Score on a Scale
Standard Deviation 24.34
|
64.9 Score on a Scale
Standard Deviation 22.29
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 6)
|
45.0 Score on a Scale
Standard Deviation 22.74
|
45.6 Score on a Scale
Standard Deviation 22.77
|
58.8 Score on a Scale
Standard Deviation 19.74
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 8)
|
65.3 Score on a Scale
Standard Deviation 25.65
|
41.6 Score on a Scale
Standard Deviation 25.54
|
66.7 Score on a Scale
Standard Deviation 21.14
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 8)
|
46.9 Score on a Scale
Standard Deviation 26.82
|
42.5 Score on a Scale
Standard Deviation 24.62
|
59.7 Score on a Scale
Standard Deviation 19.85
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 9)
|
62.8 Score on a Scale
Standard Deviation 25.86
|
43.3 Score on a Scale
Standard Deviation 24.41
|
65.5 Score on a Scale
Standard Deviation 21.99
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 9)
|
48.3 Score on a Scale
Standard Deviation 27.55
|
40.1 Score on a Scale
Standard Deviation 24.98
|
60.2 Score on a Scale
Standard Deviation 20.34
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 10)
|
66.1 Score on a Scale
Standard Deviation 25.67
|
43.1 Score on a Scale
Standard Deviation 26.52
|
67.1 Score on a Scale
Standard Deviation 23.01
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 10)
|
50.6 Score on a Scale
Standard Deviation 25.43
|
42.7 Score on a Scale
Standard Deviation 26.55
|
57.6 Score on a Scale
Standard Deviation 22.72
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 11)
|
61.6 Score on a Scale
Standard Deviation 26.54
|
44.3 Score on a Scale
Standard Deviation 25.67
|
67.2 Score on a Scale
Standard Deviation 21.63
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 11)
|
47.1 Score on a Scale
Standard Deviation 23.92
|
42.2 Score on a Scale
Standard Deviation 24.54
|
24.54 Score on a Scale
Standard Deviation 20.87
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 12)
|
63.1 Score on a Scale
Standard Deviation 26.12
|
46.5 Score on a Scale
Standard Deviation 23.72
|
69.2 Score on a Scale
Standard Deviation 20.81
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 12)
|
49.7 Score on a Scale
Standard Deviation 27.52
|
47.4 Score on a Scale
Standard Deviation 21.72
|
61.8 Score on a Scale
Standard Deviation 22.26
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 13)
|
64.9 Score on a Scale
Standard Deviation 25.41
|
40.9 Score on a Scale
Standard Deviation 24.83
|
68.6 Score on a Scale
Standard Deviation 22.41
|
|
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 13)
|
46.4 Score on a Scale
Standard Deviation 28.24
|
42.3 Score on a Scale
Standard Deviation 24.85
|
61.0 Score on a Scale
Standard Deviation 22.33
|
SECONDARY outcome
Timeframe: At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment
Participants were asked how stuffed their nose felt before and after strip application at bed time. The participants scored their responses on the scale of 0 to 3 where 0=No symptoms, 1=mild symptoms and 3=severe symptoms. These responses were recorded daily.
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 1)
|
1.95 Score on a scale
Standard Deviation 0.394
|
2.00 Score on a scale
Standard Deviation 0.562
|
1.79 Score on a scale
Standard Deviation 0.535
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 1)
|
1.10 Score on a scale
Standard Deviation 0.788
|
1.80 Score on a scale
Standard Deviation 0.696
|
1.26 Score on a scale
Standard Deviation 0.562
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 2)
|
1.80 Score on a scale
Standard Deviation 0.696
|
1.85 Score on a scale
Standard Deviation 0.587
|
1.53 Score on a scale
Standard Deviation 0.612
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 2)
|
1.05 Score on a scale
Standard Deviation 0.686
|
1.70 Score on a scale
Standard Deviation 0.733
|
1.11 Score on a scale
Standard Deviation 0.658
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 3)
|
1.90 Score on a scale
Standard Deviation 0.641
|
1.90 Score on a scale
Standard Deviation 0.553
|
1.58 Score on a scale
Standard Deviation 0.692
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 3)
|
1.16 Score on a scale
Standard Deviation 0.898
|
1.60 Score on a scale
Standard Deviation 0.754
|
1.16 Score on a scale
Standard Deviation 0.688
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 4)
|
1.55 Score on a scale
Standard Deviation 0.686
|
1.70 Score on a scale
Standard Deviation 0.733
|
1.74 Score on a scale
Standard Deviation 0.562
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 4)
|
0.95 Score on a scale
Standard Deviation 0.887
|
1.55 Score on a scale
Standard Deviation 0.759
|
1.16 Score on a scale
Standard Deviation 0.602
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 5)
|
1.75 Score on a scale
Standard Deviation 0.550
|
1.65 Score on a scale
Standard Deviation 0.671
|
1.53 Score on a scale
Standard Deviation 0.772
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 5)
|
1.00 Score on a scale
Standard Deviation 0.795
|
1.50 Score on a scale
Standard Deviation 0.761
|
1.21 Score on a scale
Standard Deviation 0.855
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 6)
|
1.90 Score on a scale
Standard Deviation 0.641
|
1.75 Score on a scale
Standard Deviation 0.716
|
1.53 Score on a scale
Standard Deviation 0.697
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 6)
|
1.00 Score on a scale
Standard Deviation 0.795
|
1.65 Score on a scale
Standard Deviation 0.813
|
1.16 Score on a scale
Standard Deviation 0.501
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 8)
|
1.70 Score on a scale
Standard Deviation 0.571
|
1.70 Score on a scale
Standard Deviation 0.571
|
1.47 Score on a scale
Standard Deviation 0.513
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 13)
|
1.75 Score on a scale
Standard Deviation 0.639
|
1.50 Score on a scale
Standard Deviation 0.688
|
1.39 Score on a scale
Standard Deviation 0.850
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 8)
|
1.15 Score on a scale
Standard Deviation 0.813
|
1.47 Score on a scale
Standard Deviation 0.772
|
0.83 Score on a scale
Standard Deviation 0.786
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 9)
|
1.70 Score on a scale
Standard Deviation 0.571
|
1.58 Score on a scale
Standard Deviation 0.838
|
1.39 Score on a scale
Standard Deviation 0.608
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 9)
|
1.05 Score on a scale
Standard Deviation 0.826
|
1.37 Score on a scale
Standard Deviation 0.955
|
1.05 Score on a scale
Standard Deviation 0.705
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 10)
|
1.60 Score on a scale
Standard Deviation 0.598
|
1.65 Score on a scale
Standard Deviation 0.933
|
1.37 Score on a scale
Standard Deviation 0.831
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 10)
|
0.95 Score on a scale
Standard Deviation 0.945
|
1.50 Score on a scale
Standard Deviation 1.051
|
1.21 Score on a scale
Standard Deviation 0.918
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 11)
|
1.68 Score on a scale
Standard Deviation 0.671
|
1.60 Score on a scale
Standard Deviation 0.821
|
1.56 Score on a scale
Standard Deviation 0.616
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 11)
|
1.15 Score on a scale
Standard Deviation 0.875
|
1.45 Score on a scale
Standard Deviation 0.945
|
1.11 Score on a scale
Standard Deviation 0.676
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 12)
|
1.74 Score on a scale
Standard Deviation 0.653
|
1.40 Score on a scale
Standard Deviation 0.754
|
1.37 Score on a scale
Standard Deviation 0.684
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 12)
|
1.05 Score on a scale
Standard Deviation 0.911
|
1.26 Score on a scale
Standard Deviation 0.872
|
0.95 Score on a scale
Standard Deviation 0.621
|
|
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip applications (Day 13)
|
0.90 Score on a scale
Standard Deviation 0.912
|
1.35 Score on a scale
Standard Deviation 0.813
|
1.05 Score on a scale
Standard Deviation 0.848
|
SECONDARY outcome
Timeframe: At Day 1, Day 2, day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
Participants were asked how stuffed their nose felt before and after strip removal in morning. The participants scored their responses on the scale of 0 to 3 where 0=No symptoms, 1=mild symptoms and 3=severe symptoms. These responses were recorded daily.
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 1)
|
1.15 Score on a scale
Standard Deviation 0.745
|
1.55 Score on a scale
Standard Deviation 0.759
|
1.22 Score on a scale
Standard Deviation 0.647
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 1)
|
1.35 Score on a scale
Standard Deviation 0.671
|
1.65 Score on a scale
Standard Deviation 0.745
|
1.33 Score on a scale
Standard Deviation 0.594
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 2)
|
1.05 Score on a scale
Standard Deviation 0.686
|
1.53 Score on a scale
Standard Deviation 0.905
|
1.21 Score on a scale
Standard Deviation 0.855
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 2)
|
1.40 Score on a scale
Standard Deviation 0.681
|
1.70 Score on a scale
Standard Deviation 0.801
|
1.32 Score on a scale
Standard Deviation 0.671
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 3)
|
0.84 Score on a scale
Standard Deviation 0.688
|
1.45 Score on a scale
Standard Deviation 0.887
|
1.11 Score on a scale
Standard Deviation 0.737
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 3)
|
1.35 Score on a scale
Standard Deviation 0.671
|
1.55 Score on a scale
Standard Deviation 0.826
|
1.11 Score on a scale
Standard Deviation 0.583
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 4)
|
0.95 Score on a scale
Standard Deviation 0.826
|
1.42 Score on a scale
Standard Deviation 0.838
|
1.00 Score on a scale
Standard Deviation 0.816
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 4)
|
1.25 Score on a scale
Standard Deviation 0.639
|
1.55 Score on a scale
Standard Deviation 0.759
|
1.11 Score on a scale
Standard Deviation 0.658
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 5)
|
0.95 Score on a scale
Standard Deviation 0.759
|
1.40 Score on a scale
Standard Deviation 0.821
|
1.00 Score on a scale
Standard Deviation 0.882
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 5)
|
1.25 Score on a scale
Standard Deviation 0.786
|
1.55 Score on a scale
Standard Deviation 0.826
|
0.95 Score on a scale
Standard Deviation 0.621
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 6)
|
1.05 Score on a scale
Standard Deviation 0.826
|
1.55 Score on a scale
Standard Deviation 0.999
|
1.00 Score on a scale
Standard Deviation 0.816
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 6)
|
1.40 Score on a scale
Standard Deviation 0.754
|
1.65 Score on a scale
Standard Deviation 0.933
|
1.05 Score on a scale
Standard Deviation 0.621
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 8)
|
1.05 Score on a scale
Standard Deviation 0.759
|
1.55 Score on a scale
Standard Deviation 0.945
|
0.84 Score on a scale
Standard Deviation 0.688
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 8)
|
1.45 Score on a scale
Standard Deviation 0.826
|
1.68 Score on a scale
Standard Deviation 0.885
|
1.00 Score on a scale
Standard Deviation 0.745
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 9)
|
0.95 Score on a scale
Standard Deviation 0.826
|
1.45 Score on a scale
Standard Deviation 1.050
|
0.79 Score on a scale
Standard Deviation 0.631
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 9)
|
1.45 Score on a scale
Standard Deviation 0.826
|
1.58 Score on a scale
Standard Deviation 1.017
|
0.95 Score on a scale
Standard Deviation 0.621
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 10)
|
0.90 Score on a scale
Standard Deviation 0.852
|
1.60 Score on a scale
Standard Deviation 0.995
|
1.00 Score on a scale
Standard Deviation 0.767
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 10)
|
1.20 Score on a scale
Standard Deviation 0.768
|
1.60 Score on a scale
Standard Deviation 0.940
|
1.21 Score on a scale
Standard Deviation 0.713
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 11)
|
1.20 Score on a scale
Standard Deviation 0.834
|
1.55 Score on a scale
Standard Deviation 0.945
|
1.00 Score on a scale
Standard Deviation 0.577
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 11)
|
1.50 Score on a scale
Standard Deviation 0.761
|
1.70 Score on a scale
Standard Deviation 0.923
|
1.21 Score on a scale
Standard Deviation 0.631
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 12)
|
1.00 Score on a scale
Standard Deviation 0.882
|
1.30 Score on a scale
Standard Deviation 1.031
|
0.74 Score on a scale
Standard Deviation 0.733
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 12)
|
1.37 Score on a scale
Standard Deviation 0.831
|
1.40 Score on a scale
Standard Deviation 0.995
|
0.95 Score on a scale
Standard Deviation 0.621
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 13)
|
0.95 Score on a scale
Standard Deviation 0.826
|
1.50 Score on a scale
Standard Deviation 1.000
|
1.00 Score on a scale
Standard Deviation 0.745
|
|
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 13)
|
1.40 Score on a scale
Standard Deviation 0.883
|
1.65 Score on a scale
Standard Deviation 0.933
|
1.05 Score on a scale
Standard Deviation 0.848
|
SECONDARY outcome
Timeframe: At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day13Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
Participants were asked how breathing felt after nasal strip was applied at bed time and removed in morning. The participants scored their responses on the scale of -5 to 5 where -5 = much worse, 0 = same and 5= much better. These responses were recorded daily.
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 1)
|
2.45 Score on a scale
Standard Deviation 1.395
|
1.20 Score on a scale
Standard Deviation 1.473
|
1.42 Score on a scale
Standard Deviation 2.116
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 1)
|
-0.30 Score on a scale
Standard Deviation 2.055
|
0.25 Score on a scale
Standard Deviation 1.650
|
0.50 Score on a scale
Standard Deviation 2.407
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 2)
|
1.95 Score on a scale
Standard Deviation 1.932
|
0.90 Score on a scale
Standard Deviation 1.410
|
1.53 Score on a scale
Standard Deviation 1.744
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 2)
|
-0.10 Score on a scale
Standard Deviation 2.075
|
0.30 Score on a scale
Standard Deviation 1.525
|
0.26 Score on a scale
Standard Deviation 2.182
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 3)
|
2.40 Score on a scale
Standard Deviation 1.667
|
1.20 Score on a scale
Standard Deviation 1.361
|
1.74 Score on a scale
Standard Deviation 1.727
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 3)
|
-0.35 Score on a scale
Standard Deviation 2.183
|
0.85 Score on a scale
Standard Deviation 1.631
|
0.68 Score on a scale
Standard Deviation 1.734
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 4)
|
2.70 Score on a scale
Standard Deviation 1.525
|
1.10 Score on a scale
Standard Deviation 1.334
|
1.47 Score on a scale
Standard Deviation 1.896
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 4)
|
-0.50 Score on a scale
Standard Deviation 2.115
|
0.45 Score on a scale
Standard Deviation 1.731
|
0.47 Score on a scale
Standard Deviation 2.118
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 5)
|
2.80 Score on a scale
Standard Deviation 1.765
|
1.05 Score on a scale
Standard Deviation 1.605
|
1.63 Score on a scale
Standard Deviation 1.707
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 5)
|
-0.20 Score on a scale
Standard Deviation 2.397
|
0.55 Score on a scale
Standard Deviation 1.731
|
0.84 Score on a scale
Standard Deviation 2.167
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 6)
|
2.85 Score on a scale
Standard Deviation 1.565
|
0.95 Score on a scale
Standard Deviation 1.504
|
1.89 Score on a scale
Standard Deviation 1.629
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 6)
|
-0.45 Score on a scale
Standard Deviation 2.282
|
0.50 Score on a scale
Standard Deviation 1.792
|
0.74 Score on a scale
Standard Deviation 2.077
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 8)
|
2.65 Score on a scale
Standard Deviation 1.755
|
0.85 Score on a scale
Standard Deviation 1.309
|
1.84 Score on a scale
Standard Deviation 1.864
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 8)
|
-0.45 Score on a scale
Standard Deviation 2.164
|
0.25 Score on a scale
Standard Deviation 1.164
|
0.79 Score on a scale
Standard Deviation 2.043
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 9)
|
2.80 Score on a scale
Standard Deviation 1.576
|
0.84 Score on a scale
Standard Deviation 1.344
|
1.84 Score on a scale
Standard Deviation 1.675
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 9)
|
-0.40 Score on a scale
Standard Deviation 2.415
|
0.20 Score on a scale
Standard Deviation 1.196
|
1.00 Score on a scale
Standard Deviation 1.856
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 10)
|
2.85 Score on a scale
Standard Deviation 1.599
|
0.95 Score on a scale
Standard Deviation 1.234
|
1.95 Score on a scale
Standard Deviation 1.580
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 10)
|
-0.47 Score on a scale
Standard Deviation 2.412
|
0.25 Score on a scale
Standard Deviation 1.251
|
1.00 Score on a scale
Standard Deviation 2.082
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 11)
|
2.60 Score on a scale
Standard Deviation 1.759
|
0.75 Score on a scale
Standard Deviation 1.293
|
1.84 Score on a scale
Standard Deviation 1.675
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 11)
|
-0.65 Score on a scale
Standard Deviation 2.277
|
0.10 Score on a scale
Standard Deviation 1.410
|
0.68 Score on a scale
Standard Deviation 2.056
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 12)
|
2.79 Score on a scale
Standard Deviation 1.782
|
0.95 Score on a scale
Standard Deviation 1.317
|
2.00 Score on a scale
Standard Deviation 1.491
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 12)
|
-0.74 Score on a scale
Standard Deviation 2.306
|
0.30 Score on a scale
Standard Deviation 1.218
|
0.89 Score on a scale
Standard Deviation 2.052
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 13)
|
2.65 Score on a scale
Standard Deviation 1.631
|
0.95 Score on a scale
Standard Deviation 1.317
|
2.05 Score on a scale
Standard Deviation 1.649
|
|
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 13)
|
-0.40 Score on a scale
Standard Deviation 2.703
|
0.35 Score on a scale
Standard Deviation 1.424
|
0.79 Score on a scale
Standard Deviation 1.988
|
SECONDARY outcome
Timeframe: At Day 7 and at Day 14Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
Participants scored all the domains of NRQLQ using same 7 points scale where 0=Not troubled and 6=extremely troubled. Sleep problems (difficulty getting sleep, unable to get a good night sleep or wake up during the night, restless \[tossing and turning\] and having to get up because stuffy nose or to blow nose using the score, scores range: Min-Max \[0-24\]), Sleep time problems (Nasal congestion or stuffy nose, sinus pressure or pain, runny nose, post-nasal drip \[drainage down back of nose/throat\], and headache, scores range: 0-30); Symptoms on waking in the morning (Feel tired and unrefreshed, nasal congestion or stuffy nose, congestion in sinuses, takes time to clear nighttime drainage after waking up, scores range:0-24); practical problems (have to avoid symptom triggers such as dust, cigarette smoke, strong smells and perfumes, need to rub nose or eyes, and have to take medication, scores range: 0-18). Lower scores indicate improvement in the rhinitis symptoms.
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Change From Baseline in Mean Average Score of NRQLQ for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7 and Day 14 in Participants With the Risk of Sleep Apnea.
Sleep Problems (Day 7)
|
7.62 Score on a scale
Standard Deviation 6.117
|
11.58 Score on a scale
Standard Deviation 7.452
|
6.09 Score on a scale
Standard Deviation 4.826
|
|
Change From Baseline in Mean Average Score of NRQLQ for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7 and Day 14 in Participants With the Risk of Sleep Apnea.
Sleep Problems (Day 14)
|
6.92 Score on a scale
Standard Deviation 5.951
|
9.75 Score on a scale
Standard Deviation 6.771
|
4.91 Score on a scale
Standard Deviation 4.134
|
|
Change From Baseline in Mean Average Score of NRQLQ for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7 and Day 14 in Participants With the Risk of Sleep Apnea.
Sleep time problems (Day 7)
|
7.62 Score on a scale
Standard Deviation 6.838
|
10.08 Score on a scale
Standard Deviation 7.489
|
6.00 Score on a scale
Standard Deviation 7.225
|
|
Change From Baseline in Mean Average Score of NRQLQ for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7 and Day 14 in Participants With the Risk of Sleep Apnea.
Sleep time problems (Day 14)
|
6.77 Score on a scale
Standard Deviation 7.683
|
8.50 Score on a scale
Standard Deviation 8.713
|
6.18 Score on a scale
Standard Deviation 7.054
|
|
Change From Baseline in Mean Average Score of NRQLQ for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7 and Day 14 in Participants With the Risk of Sleep Apnea.
Symptoms on waking in morning (Day 7)
|
8.69 Score on a scale
Standard Deviation 6.701
|
12.00 Score on a scale
Standard Deviation 5.673
|
5.45 Score on a scale
Standard Deviation 4.228
|
|
Change From Baseline in Mean Average Score of NRQLQ for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7 and Day 14 in Participants With the Risk of Sleep Apnea.
Symptoms on waking in morning (Day 14)
|
8.31 Score on a scale
Standard Deviation 5.936
|
10.42 Score on a scale
Standard Deviation 6.543
|
5.00 Score on a scale
Standard Deviation 4.472
|
|
Change From Baseline in Mean Average Score of NRQLQ for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7 and Day 14 in Participants With the Risk of Sleep Apnea.
Practical problems (Day 7)
|
3.00 Score on a scale
Standard Deviation 5.033
|
4.67 Score on a scale
Standard Deviation 3.601
|
2.55 Score on a scale
Standard Deviation 3.503
|
|
Change From Baseline in Mean Average Score of NRQLQ for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7 and Day 14 in Participants With the Risk of Sleep Apnea.
Practical Problems (Day 14)
|
2.54 Score on a scale
Standard Deviation 4.858
|
3.08 Score on a scale
Standard Deviation 3.059
|
2.64 Score on a scale
Standard Deviation 2.942
|
SECONDARY outcome
Timeframe: At Day 7 and Day 14Participants scored all two domains of NRQLQ using same 7 points scale: 0=Not troubled, 1=Hardly troubled, 3=moderately troubled, 4=quite a bit troubled, 5=very troubled, 6=extremely troubled. Domains were Sleep problems (difficulty getting sleep, unable to get a good night sleep or wake up during the night, restless \[tossing and turning\] and having to get up because stuffy nose or to blow nose using the score), and Symptoms on waking in the morning (Feel tired and unrefreshed, nasal congestion or stuffy nose, congestion in sinuses, takes time to clear nighttime drainage after waking up); Lower scores indicate improvement in the rhinitis symptoms.
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Number of Participants Showing Improvement for Sleep Problems and Symptoms on Waking in the Morning Domain of the NRQLQ
All sleep problems (Day 7)
|
14 Participants
|
5 Participants
|
11 Participants
|
|
Number of Participants Showing Improvement for Sleep Problems and Symptoms on Waking in the Morning Domain of the NRQLQ
All sleep problems (Day 14)
|
12 Participants
|
10 Participants
|
13 Participants
|
|
Number of Participants Showing Improvement for Sleep Problems and Symptoms on Waking in the Morning Domain of the NRQLQ
Any sleep problems (Day 7)
|
18 Participants
|
18 Participants
|
19 Participants
|
|
Number of Participants Showing Improvement for Sleep Problems and Symptoms on Waking in the Morning Domain of the NRQLQ
Any sleep problems (Day 14)
|
20 Participants
|
19 Participants
|
17 Participants
|
|
Number of Participants Showing Improvement for Sleep Problems and Symptoms on Waking in the Morning Domain of the NRQLQ
All symptoms on waking (Day 7)
|
14 Participants
|
11 Participants
|
14 Participants
|
|
Number of Participants Showing Improvement for Sleep Problems and Symptoms on Waking in the Morning Domain of the NRQLQ
All symptoms on waking (Day 14)
|
14 Participants
|
11 Participants
|
16 Participants
|
|
Number of Participants Showing Improvement for Sleep Problems and Symptoms on Waking in the Morning Domain of the NRQLQ
Any symptoms on waking (Day 7)
|
19 Participants
|
17 Participants
|
19 Participants
|
|
Number of Participants Showing Improvement for Sleep Problems and Symptoms on Waking in the Morning Domain of the NRQLQ
Any symptoms on waking (Day 14)
|
19 Participants
|
18 Participants
|
19 Participants
|
SECONDARY outcome
Timeframe: on first night (Night 1) of each daily diary questionPopulation: Analysis for this outcome was performed on intent-to-treat (ITT) population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
Participants were asked Q2 (How stuffed does your nose feel at this time?) and Q4 (How Breathing felt after the nasal strip was applied) of daily diary questions. Q2 was scored on 4 point scale where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, 3=severe symptoms and Q4 on 11 point scale where -5=much worse, 0=same, 5=much better.
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Number of Participants Showing Improvement for Daily Diary Questions (Q2 and Q4)
Q2
|
13 Participants
|
3 Participants
|
10 Participants
|
|
Number of Participants Showing Improvement for Daily Diary Questions (Q2 and Q4)
Q4
|
18 Participants
|
11 Participants
|
12 Participants
|
SECONDARY outcome
Timeframe: on first night (Night 1) of each daily diary questionPopulation: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.
Participants were asked following daily diary VAS scale questions a) How easy it was to breathe through your nose and b) How open their nose feels at this time. Both of these questions were scored using 100 mm VAS scale where, 0=extremely difficult, 100=extremely easy.
Outcome measures
| Measure |
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
Number of Participants Showing Improvement for VAS Scale Daily Diary Questions
Easy to breathe
|
20 Participants
|
11 Participants
|
15 Participants
|
|
Number of Participants Showing Improvement for VAS Scale Daily Diary Questions
Openness
|
19 Participants
|
13 Participants
|
13 Participants
|
Adverse Events
Marketed Nasal Strip
Placebo Nasal Strip
Prototype Nasal Dilator
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Marketed Nasal Strip
n=20 participants at risk
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Placebo Nasal Strip
n=21 participants at risk
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
Prototype Nasal Dilator
n=19 participants at risk
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
|
|---|---|---|---|
|
General disorders
Nasal scab secondary to strip removal
|
0.00%
0/20
|
4.8%
1/21
|
0.00%
0/19
|
Additional Information
GSK Response Center
GlaxoSmithKline
Results disclosure agreements
- Principal investigator is a sponsor employee GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
- Publication restrictions are in place
Restriction type: OTHER